Others, such as TCF12 and NIPBL, are less commonly associated with cancer or drug resistance; TCF12 is classified as a lower-confidence cancer gene in OncoKB, and NIPBL is not listed, suggesting potential novel roles in mediating transcriptional reprogramming. This evidence concerns the gene TCF12 and cancer.